European equities struggle and Nasdaq futures rise as investors focus on Fed earnings and big tech


<div id=”js-article__body” itemprop=”articleBody” data-sbid=”WP-MKTW-0000143600″>

European stocks struggled for traction on Wednesday, with investors focused on the company’s results and a meeting of the Federal Reserve for later. Nasdaq-100 futures were higher on Microsoft’s results. The Stoxx Europe 600 SXXP Index, + 0.00% was up 0.1% to 408.17, following a 0.6% rise on Tuesday. Regional exchanges were mixed, with the German DAX DAX, -0.32% minus 0.2%, the French CAC 40 PX1, + 0.14% to 0.3%, and the FTSE 100 UKX index, -0, 00% flat.

After a slightly weaker close for Wall Street on Tuesday, Nasdaq-100 NQ00 futures, + 0.49% traded higher after tech giant Microsoft MSFT, + 1.22% reported record earnings, reaching $ 40 billion in sales. quarterly for the first time. Investors will see results from tech giants Apple AAPL, + 0.17% and Facebook FB, + 1.45%, along with electric car maker Tesla TSLA, + 0.26% after the close of business on Wednesday. Investors will also receive a decision from the Federal Reserve, followed by a press conference with President Jerome Powell, in the hope that the central bank will continue its stance of support for the markets amid the COVID-19 pandemic. Worldwide coronavirus infections passed the 100 million mark on Tuesday, according to a tally by Johns Hopkins University. The UK also reached a milestone on Tuesday, surpassing 100,000 deaths from COVID-19, the first European country to do so. Home Minister Priti Patel is expected to announce new rules on Wednesday to limit the influx of visitors to UK shares of Royal KPN KPN, + 4.22% up 4%, after the Dutch telecom company said that fourth quarter net earnings more than doubled. for exceptional items. It also raised its cash flow guidance for 2021. Sanofi SNY shares, -0.97% SAN, + 0.95% gained 0.7%, after the pharmaceutical group said it would help BioNTech BNTX, -3 , 91% to produce the COVID-19 vaccine that is. joint development with US pharmaceutical company Pfizer PFE, + 0.08%. Sanofi said it will continue to develop its two candidates against COVID-19. Sanofi and British pharmaceutical group GlaxoSmithKline GSK, + 0.82% GSK, + 0.04% announced a delay in their COVID-19 joint vaccine in December after early trials showed an insufficient response in older patients. Read: Tensions rise in Europe over AstraZeneca COVID-19 EDF EDF vaccine problems, -2.56% shares fell 2%, after the French power company published an updated calendar and cost estimates for the plant Hinkley Point C nuclear power plant, saying it sees a delay and higher costs due to the pandemic. Shares of technology company ASML ASML, -3.28% ASML, -2.08% fell 1.6%. Another big decline was Danish shipping giant AP Moller-Maersk MAERSK.A, -6.55%, whose shares fell 6%.